|
1
|
Yang SY: Sniper the hyperplasia of mammary
glands and escort for the women health. Med People. 34–35.
2007.
|
|
2
|
Jun JY, Griffith JW, Bruggeman R, et al:
Effects of polyamine depletion by alpha-difluoromethylornithine on
in vitro and in vivo biological properties of 4T1
murine mammary cancer cells. Breast Cancer Res Treat. 107:33–40.
2008.PubMed/NCBI
|
|
3
|
Garcia R, Yu CL, Hudnall A, et al:
Constitutive activation of Stat3 in fibroblasts transformed by
diverse oncoproteins and in breast carcinoma cells. Cell Growth
Differ. 8:1267–1276. 1997.PubMed/NCBI
|
|
4
|
Yu H and Jove R: The STATs of cancer – new
molecular targets come of age. Nat Rev Cancer. 4:97–105. 2004.
|
|
5
|
Frank DA: STAT3 as a central mediator of
neoplastic cellular transformation. Cancer Lett. 251:199–210. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Darnell JE Jr: Transcription factors as
targets for cancer therapy. Nat Rev Cancer. 2:740–749. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chiu WT, Lee HT, Huang FJ, et al:
Caveolin-1 upregulation mediates suppression of primary breast
tumor growth and brain metastases by stat3 inhibition. Cancer Res.
71:4932–4943. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Blaskovich MA, Sun J, Cantor A, et al:
Discovery of JSI-124 (cucurbitacin I), a selective Janus
kinase/signal transducer and activator of transcription 3 signaling
pathway inhibitor with potent antitumor activity against human and
murine cancer cells in mice. Cancer Res. 63:1270–1279. 2003.
|
|
9
|
Leong PL, Andrews GA, Johnson DE, et al:
Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates
head and neck cancer cell growth. Proc Natl Acad Sci USA.
100:4138–4143. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meydan N, Grunberger T, Dadi H, et al:
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor.
Nature. 379:645–648. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mora LB, Buettner R, Seigne J, et al:
Constitutive activation of Stat3 in human prostate tumors and cell
lines: direct inhibition of Stat3 signaling induces apoptosis of
prostate cancer cells. Cancer Res. 62:6659–6666. 2002.PubMed/NCBI
|
|
12
|
Nakajima K, Yamanaka Y, Nakae K, et al: A
central role for Stat3 in IL-6-induced regulation of growth and
differentiation in M1 leukemia cells. EMBO J. 15:3651–3658.
1996.PubMed/NCBI
|
|
13
|
Ni Z, Lou W, Leman ES, et al: Inhibition
of constitutively activated Stat3 signaling pathway suppresses
growth of prostate cancer cells. Cancer Res. 60:1225–1228.
2000.PubMed/NCBI
|
|
14
|
de Fougerolles A, Vornlocher HP,
Maraganore J and Liberman J: Interfering with disease: a progress
report on siRNA-based therapeutics. Nat Rev Drug Discov. 6:443–453.
2007.PubMed/NCBI
|
|
15
|
Akhtar S and Benter I: Toxicogenomics of
non-viral drug delivery systems for RNAi: potential impact on
siRNA-mediated gene silencing activity and specificity. Adv Drug
Deliv Rev. 59:164–182. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bumcrot D, Manoharan M, Koteliansky V and
Sah DW: RNAi therapeutics: a potential new class of pharmaceutical
drugs. Nat Chem Biol. 2:711–719. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakamura Y, Kogure K, Futaki S and
Harashima H: Octaarginine-modified multifunctional envelope-type
nano device for siRNA. J Control Release. 119:360–367. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Agerberth B, Lee JY, Bergman T, et al:
Amino acid sequence of PR-39. Isolation from pig intestine of a new
member of the family of proline-arginine-rich antibacterial
peptides. Eur J Biochem. 202:849–854. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Boman HG, Agerberth B and Boman A:
Mechanisms of action on Escherichia coli of cecropin P1 and
PR-39, two antibacterial peptides from pig intestine. Infect Immun.
61:2978–2984. 1993.PubMed/NCBI
|
|
20
|
Storici P and Zanetti M: A cDNA derived
from pig bone marrow cells predicts a sequence identical to the
intestinal antibacterial peptide PR-39. Biochem Biophys Res Commun.
196:1058–1065. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shi J, Ross CR, Leto TL and Blecha F:
PR-39, a proline-rich antibacterial peptide that inhibits phagocyte
NADPH oxidase activity by binding to Src homology 3 domains of
p47phox. Proc Nat Acad Sci USA. 93:6014–6018. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chan YR and Gallo RL: PR-39, a
syndecan-inducing antimicrobial peptide, binds and affects
p130(Cas). J Biol Chem. 273:28978–28985. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gao Y, Lecker S, Post MJ, et al:
Inhibition of ubiquitin-proteasome pathway–mediated I kappa B alpha
degradation by a naturally occurring antibacterial peptide. J Clin
Invest. 106:439–448. 2000.
|
|
24
|
Alshamsan A, Hamdy S, Samuel J, et al: The
induction of tumor apoptosis in B16 melanoma following STAT3 siRNA
delivery with a lipid-substituted polyethylenimine. Biomaterials.
31:1420–1428. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ye Y, Yin DT, Chen L, et al:
Identification of Piwil2-like (PL2L) proteins that promote
tumorigenesis. PLoS One. 5:e134062010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ohtake T, Fujimoto Y, Ikuta K, et al:
Proline-rich antimicrobial peptide, PR39 gene transduction altered
invasive activity and actin structure in human hepatocellular
carcinoma cells. Br J Cancer. 81:393–403. 1999. View Article : Google Scholar
|
|
27
|
Ohki EC, Tilkins ML, Ciccarone VC and
Price PJ: Improving the transfection efficiency of post-mitotic
neurons. J Neurosci Methods. 112:95–99. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang YH, Chen CP, Chan MH, et al:
Arginine-rich intracellular delivery peptides noncovalently
transport protein into living cells. Biochem Biophys Res Commun.
346:758–767. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang YH, Hou YW and Lee HJ: An
intracellular delivery method for siRNA by an arginine-rich
peptide. J Biochem Biophys Methods. 70:579–586. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim SW, Kim NY, Choi YB, et al: RNA
interference in vitro and in vivo using an arginine
peptide/siRNA complex system. J Control Release. 143:335–343.
2010.PubMed/NCBI
|
|
31
|
Zhang X, Oglecka K, Sandgren S, et al:
Dual functions of the human antimicrobial peptide LL-37-target
membrane perturbation and host cell cargo delivery. Biochim Biophys
Acta. 1798:2201–2208. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hoskin DW and Ramamoorthy A: Studies on
anticancer activities of antimicrobial peptides. Biochim Biophys
Acta. 1778:357–375. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Veldhoen S, Laufer SD, Trampe A and Restle
T: Cellular delivery of small interfering RNA by a non-covalently
attached cell-penetrating peptide: quantitative analysis of uptake
and biological effect. Nucleic Acids Res. 34:6561–6573. 2006.
View Article : Google Scholar : PubMed/NCBI
|
